Vycor Medical (VYCO) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -20.77% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 8.34% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 18.67% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.93% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -50.44% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 43.57% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -58.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64% |
| Dec 31, 2025 | 26.84% |
| Sep 30, 2025 | 31.46% |
| Jun 30, 2025 | 36.56% |
| Mar 31, 2025 | 46.59% |
| Dec 31, 2024 | 27.46% |
| Sep 30, 2024 | 36.53% |
| Jun 30, 2024 | -25.50% |
| Mar 31, 2024 | 70.19% |
| Dec 31, 2023 | 37.88% |
| Sep 30, 2023 | 57.31% |
| Jun 30, 2023 | 31.52% |
| Mar 31, 2023 | 28.42% |
| Dec 31, 2022 | -89.22% |
| Sep 30, 2022 | 35.14% |
| Jun 30, 2022 | 33.08% |
| Mar 31, 2022 | 41.97% |
| Dec 31, 2021 | -31.75% |
| Sep 30, 2021 | 21.28% |
| Jun 30, 2021 | 26.09% |